Research Topics
| Neil FleshnerSummaryAffiliation: University of Toronto Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4David Cervi
1Department of Molecular and Cellular Biology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada
BMC Cancer 10:258. 2010..The purpose herein was to discover, validate and characterize functional biomarkers of dietary supplementation capable of suppressing the course of prostate cancer in vivo...
Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and seleniumNeil E Fleshner
University Health Network, Princess Margaret Hospital, 610 University Ave, Toronto, Ontario Canada
J Clin Oncol 29:2386-90. 2011..This hypothesis was tested in a randomized phase III double-blind study of daily soy (40 g), vitamin E (800 U), and selenium (200 μg) versus placebo...
Should finasteride be used to prevent prostate cancer?Neil Fleshner
University Health Network, 610 University Avenue, 3 130, Toronto, Ontario, M5G 2M9, Canada
Curr Treat Options Oncol 7:346-54. 2006..Additional trials of antiestrogens, micronutrients, and other 5ARIs, which will mature over the next 2 to 5 years, will better define the role of 5ARIs in prostate cancer chemoprevention...
Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trialNeil Fleshner
University Health Network, Princess Margaret Hospital, Toronto, ON, Canada
Contemp Clin Trials 28:763-9. 2007..Dutasteride, a dual 5alpha-reductase inhibitor (5ARI), may delay prostate cancer progression or extend the time to initiation of more aggressive therapy...
Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged<or=55 years with favorable prostate cancerAlfonso Gómez-Iturriaga Piña
Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, Canada
Urology 75:1412-6. 2010..To report the genitourinary (GU) and gastrointestinal (GI) toxicity rates, erectile function preservation, and biochemical outcome (bNED) in men aged<or=55 years treated with 125iodine (125I) brachytherapy (BT)...
A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studiesStephane Supiot
Princess Margaret Hospital University Health Network, Toronto, Ont, Canada
Radiother Oncol 88:53-60. 2008..In a phase I trial, we investigated the feasibility of pre-operative radiotherapy for this patient subset...
'Prostatic evasive anterior tumours': the role of magnetic resonance imagingNathan Lawrentschuk
University of Toronto, ON, Canada
BJU Int 105:1231-6. 2010....
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitorsDean Sol Elterman
Princess Margaret Hospital, Toronto, Ontario, Canada
J Urol 183:2085-9. 2010..Thus, we determined whether pharmacological doses of alpha-blockers and/or 5alpha-reductase inhibitors were present in a sample of phytotherapeutic agents for benign prostatic hyperplasia...
Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsiesJocelyn Stewart
Department of Pathology, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada
J Urol 179:1751-5; discussion 1755. 2008..This study evaluates the prognostic significance of alpha-methylacyl-coA racemase positive high grade prostatic intraepithelial neoplasia glands in prostate biopsies...
Correlation of ERG expression and DNA methylation biomarkers with adverse clinicopathologic features of prostate cancerKen Kron
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
Clin Cancer Res 18:2896-904. 2012..The aim of this study was to analyze the relationship between ERG expression, DNA methylation of three biomarkers, and clinicopathologic features of prostate cancer...
Extended pattern prostate biopsy does not minimize the volume-grade bias in prostate cancer detectionAbdullah M Al-Ghamdi
University Health Network, University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada
J Urol 179:1332-4. 2008..A basic tenet of measurement theory is that repeat measurement improves validity. We determined whether an extended pattern prostate biopsy technique could overcome this bias...
The role of 5-alpha-reductase inhibitors in active surveillanceDavid Margel
Division of Urology, Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
Curr Opin Urol 22:243-6. 2012..In this context, we will present recent data on the efficacy of 5-alpha-reductase inhibitors (5-ARIs) in secondary prevention among men with low-risk PCa choosing active surveillance...
mTOR-RAPTOR and 14-3-3σ immunohistochemical expression in high grade prostatic intraepithelial neoplasia and prostatic adenocarcinomas: a tissue microarray studySevan Evren
Department of Laboratory Medicine, University Health Network, Toronto, Ontario, Canada
J Clin Pathol 64:683-8. 2011..The correlation of mTOR, RAPTOR and 14-3-3σ in high grade prostatic intraepithelial neoplasia (HGPIN) and prostate cancer has not previously been investigated...
Prostate-specific antigen test result interpretation when combined with risk factors for recommendation of biopsy: a survey of urologist's practice patternsNathan Lawrentschuk
Division of Urology, Department of Surgical Oncology, Princess Margaret Hospital, 610 University Ave 3 130, Toronto, ON, M5G 2M9, USA
Int Urol Nephrol 43:31-7. 2011..Our aim was to conduct a contemporary survey of urologist's practice patterns toward PC detection, specifically focusing on factors determining the decision to recommend ultrasound-guided biopsy (TRUS-BX)...
Impact of positive surgical margins after radical prostatectomy differs by disease risk groupSultan Alkhateeb
Division of Urology, Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
J Urol 183:145-50. 2010..We examined the relationship of positive surgical margins to biochemical progression according to several clinicopathological features...
Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinomaRobert Abouassaly
Division of Urologic Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Urology 76:895-901. 2010..Complete nephroureterectomy is the standard of care, and increasing evidence has shown that a suboptimal surgical technique is associated with an adverse prognosis...
Protective effect of metformin in CD1 mice placed on a high carbohydrate-high fat dietMin Hou
Division of Urology, Sunnybrook Health Science Centre, Toronto, Ontario, Canada
Biochem Biophys Res Commun 397:537-42. 2010..These effects may explain its translational role relating to its anti-neoplastic potential...
Transperitoneal laparoscopic prostatectomy does not increase small bowel within the target volume for postoperative radiotherapyAntonio Finelli
Princess Margaret Hospital, Toronto, Ontario, Canada
J Urol 182:2280-4. 2009..We compared the incidence of small bowel within the planning target volume for radiotherapy to the prostate bed in patients who underwent open retropubic and laparoscopic radical prostatectomy...
Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancerShabbir M H Alibhai
University Health Network, Toronto, Ontario, Canada
J Clin Oncol 28:5030-7. 2010..To evaluate the effects of androgen-deprivation therapy (ADT) on cognitive function in men with nonmetastatic prostate cancer (PC)...
Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention TrialJuanita Mary Crook
University of Toronto, University Health Network, and Princess Margaret Hospital, Toronto, Ontario, Canada
J Clin Oncol 29:362-8. 2011..We report health-related quality of life (HRQOL) at a mean of 5.3 years for 168 trial-eligible men who either chose or were randomly assigned to RP or BT following a multidisciplinary educational session...
Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observationPeter S Bunting
Department of Clinical Pathology, Sunnybrook and Women s College Health Sciences Centre, Toronto, Ontario, Canada
Clin Biochem 35:471-5. 2002..To determine the intraindividual variation of prostate-specific antigen (PSA) isoforms in prostate cancer patients managed conservatively with watchful observation...
Information needs of men on androgen deprivation therapyTony Soeyonggo
University of Toronto, Toronto, Canada
BJU Int 109:1503-9. 2012..A key area to enhance patient education appears to be side effects, especially around hot flashes and fatigue, which were also the most bothersome treatment sequelae for patients...
External validation of a biomarker based pre-cystectomy algorithm to predict nonorgan confined urothelial cancersDavid Margel
Division of Urology, Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Canada
J Urol 187:840-4. 2012..This algorithm included tumor markers (CEA, CA 125 and CA 19-9) as well as clinical parameters. In this study we validated the accuracy of this algorithm in an independent, external cohort...
Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort studyDavid Margel
Division of Urology, Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
J Urol 187:1247-52. 2012..We report magnetic resonance imaging findings among unselected men with low risk prostate cancer before active surveillance...
Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray studyJocelyn Stewart
Department of Pathology, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada
J Clin Pathol 60:773-80. 2007..Current ancillary markers for diagnosis in prostate biopsies include p63 and alpha-methylacyl-CoA racemase (AMACR). Annexin II (ANXII), a calcium and phospholipid binding protein, is lost in prostate cancer...
Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mLRami Al Azab
Division of Urology, Princess Margaret Hospital, Toronto, Ontario, Canada
Urology 69:103-7. 2007..0 and 9.0 ng/mL. If this hypothesis were correct, within these ranges, a smaller prostate volume would be a stronger predictor of cancer than the PSA level itself (the relative contribution from cancer is greater in smaller glands)...
Variation in patterns of practice in diagnosing screen-detected prostate cancerRobert K Nam
Division of Urology, Sunnybrook and Women s College Health Sciences Centre, University of Toronto, Toronto, Canada
BJU Int 94:1239-44. 2004....
The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levelsNathan Lawrentschuk
Division of Urology, University Health Network, University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada
BJU Int 103:730-3. 2009..A comparison study and cost-benefit analysis of MRI-targeted vs saturation biopsy in this group of patients would also be ideal, to delineate any advantages...
Rethinking 30-day mortality risk after radical prostatectomyShabbir M H Alibhai
Division of General Internal Medicine and Clinical Epidemiology, University Health Network, Toronto, Ontario, Canada
Urology 68:1057-60. 2006..Although radical prostatectomy (RP) is associated with greater 30-day mortality in older men, the magnitude of the excess risk in older age groups compared with younger ones has not been well characterized...
Management of low-stage testicular seminomaMischel Neill
Division of Urology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
Urol Clin North Am 34:127-36; abstract vii-viii. 2007..Radiation therapy remains the mainstay of therapy for patients who have stage IIa disease...
Defining high-risk prostate cancer: current statusNeil Fleshner
Division of Urology, University Health Network, University of Toronto, Toronto, Ontario, Canada
Can J Urol 12:14-7; discussion 94-6. 2005..Softer risk factors such as obesity, race, socioeconomic status, and genetic polymorphisms are increasingly being studied. Ultimately high-throughput genomics will aid in identification of these men...
Antiproliferative mechanisms of the flavonoids 2,2'-dihydroxychalcone and fisetin in human prostate cancer cellsAhmed Q Haddad
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Nutr Cancer 62:668-81. 2010..Other functional categories altered included chromosome organization, apoptosis, and stress response. These results demonstrate the multiple mechanisms of antitumor activity of DHC and fisetin in prostate cancer cells in vitro...
A whole-genome SNP association study of NCI60 cell line panel indicates a role of Ca2+ signaling in selenium resistanceSevtap Savas
Fred A Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
PLoS ONE 5:e12601. 2010....
Perineural invasion on prostate biopsy does not predict adverse pathological outcomeMalik Elharram
University of Toronto, Toronto, Ontario, Canada
Can J Urol 19:6567-72. 2012..The aim of this present study is to determine the role of PNI on prostate biopsy in predicting adverse findings at radical prostatectomy in a recent cohort of screen detected prostate cancer...
Efficacy of a second line luteinizing hormone-releasing hormone agonist after advanced prostate cancer biochemical recurrenceNathan Lawrentschuk
University of Toronto, University Health Network, Department of Urology, Princess Margaret Hospital, Toronto, Ontario, Canada
J Urol 185:848-54. 2011..Secondary objectives were to calculate the PSA response and determine whether sequence order impacted the response...
Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancerAbbas H Panju
Department of Medicine, University Health Network, Toronto, Ontario, Canada
BJU Int 103:753-7. 2009....
A reliable coding system to define screening prostate-specific antigen tests was developed in a case-control studyPeter S Bunting
Division of Biochemistry, Department of Pathology and Laboratory Medicine, University of Ottawa, Ontario, Canada
J Clin Epidemiol 58:639-44. 2005..To establish the reliability of a coding system for screening and diagnostic prostate-specific antigen (PSA) testing from patient charts...
Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trialKris Wallace
Department of Radiation Medicine and the Division of Urology, Princess Margaret Hospital, University Health Network, Toronto, Canada
J Clin Oncol 24:4158-62. 2006....
Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): a tissue microarray study (TMA)Sevan Evren
Department of Laboratory Medicine, University Health Network, Toronto, ON, Canada
Prostate 70:1429-36. 2010..Upregulation of this pathway can lead to an aberrant increase in cell growth and metabolism characteristic of malignant transformation...
Does prolonging the time to renal cancer surgery affect long-term cancer control: a systematic review of the literatureMichael Jewett
University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada
Can J Urol 13:54-61. 2006..e., recurrence-free survival, overall survival)?..
Diminished efficacy of Bacille Calmette-Guérin among elderly patients with nonmuscle invasive bladder cancerDavid Margel
Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
Urology 78:848-54. 2011..Given that immune response is attenuated with age, we set out to determine the impact of age on response to BCG...
The effect of radiation on semen quality and fertility in men treated with brachytherapy for early stage prostate cancerDilpreet K Singh
Division of Urology, Princess Margaret Hospital and Mount Sinai Hospital, Toronto, Ontario, Canada
J Urol 187:987-9. 2012..We determined the effects of prostatic brachytherapy on semen parameters and sperm DNA integrity, and the potential impact on fertility...
The fate of an unsatisfactory urine cytology test among patients with urothelial carcinomaMichael Ordon
Department of Pathology, University Health Network, Toronto, Canada
BJU Int 104:1641-5. 2009....
Surgical wait times for patients with urological cancers: a survey of Canadian surgeonsNeil Fleshner
University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada
Can J Urol 13:3-13. 2006..These issues need to be addressed through a partnership between the key stakeholders in order to reduce the potentially negative impact on clinical outcomes and patient quality of life...
Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristicsHeather Boon
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
Urology 62:849-53. 2003..CAM use appears to be more related to other factors such as support group attendance, disease characteristics, and beliefs about CAM. Our findings highlight the need for urologists to ask all their patients about their use of CAM...
Prostate cancer: chemoprevention update 2005Neil Fleshner
Department of Surgery (Urology, University Health Network and University of Toronto, Toronto, Ontario, Canada
Can J Urol 12:2-4. 2005..CONCLUSION: Tantalizing prospects for effective chemoprevention of prostate cancer exist. Fortunately, well-conducted randomized trials will allow us to answer many of these questions within the next 2 to 8 years...
Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic menDavid J A Jenkins
Clinical Nutrition and Risk Factor Modification Center, St. Michael's Hospital, 61 Queen St. East, Toronto, Ontario, Canada M5C 2T2
J Urol 169:507-11. 2003..CONCLUSIONS: At levels of soy intake which reduce low-density lipoprotein cholesterol any potential benefits of soy consumption on prostate cancer are likely to occur for reasons other than alterations in hormone activity...
Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic casesNeil Fleshner
Department of Urology (Surgery, Toronto Regional Cancer Centre, University of Toronto, Toronto, Ontario, Canada
Urology 60:93-7. 2002..The marginal utility of the saturation biopsy is low. Although rare additional cases will be detected using this technique, 18-core peripheral sampling is recommended for these difficult diagnostic cases...
Most renal oncocytomas appear to grow: observations of tumor kinetics with active surveillanceSarah Kawaguchi
Division of Urology, Department of Surgery, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
J Urol 186:1218-22. 2011..We examined the growth of tissue proven renal oncocytoma on serial imaging to improve our understanding of its natural history...
30-day mortality and major complications after radical prostatectomy: influence of age and comorbidityShabbir M H Alibhai
Division of General Internal Medicine and Clinical Epidemiology, University Health Network, Toronto, Canada
J Natl Cancer Inst 97:1525-32. 2005..Prior studies have suggested an increased risk of short-term complications among older men who underwent radical prostatectomy, but these studies did not adjust for comorbidity...
Remission of hormone-refractory prostate cancer attributed to EssiacWigdan Al-Sukhni
Division of Urology, The Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Can J Urol 12:2841-2. 2005..We describe here the case of a 64-year-old man whose hormone-refractory prostate cancer responded well to Essiac tea...
Dietary fat and prostate cancerNeil Fleshner
Division of Urology and Department of Surgical Oncology, Princess Margaret Hospital, University of Toronto, Canada
J Urol 171:S19-24. 2004..We provide a critical appraisal of the existing evidence for an association between dietary fat consumption and prostate cancer, and review the biologically plausible relationships...
Long-term urinary sequelae following 125iodine prostate brachytherapyJuanita Crook
Department of Radiation Oncology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada
J Urol 179:141-5; discussion 146. 2008..We describe long-term urinary function in men treated with 125iodine brachytherapy without supplemental beam irradiation...
Climacturia following radical prostatectomy: prevalence and risk factorsJason Lee
University Health Network (Princess Margaret Hospital, University of Toronto, Toronto, Ontario
J Urol 176:2562-5; discussion 2565. 2006..It can be a significant problem with respect to urine volume loss, associated bother and condom use. Patients must be informed about this complication before undergoing radical prostatectomy...
Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarraysKen Kron
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
PLoS ONE 4:e4830. 2009..Such occurrences often lead to the silencing of these key genes and thus they may contribute to the development of cancer, including prostate cancer...
Papillary renal cell carcinoma within a renal oncocytoma: case report of an incidental finding of a tumour within a tumourCorwyn Rowsell
Department of Pathology and Laboratory Medicine, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
J Clin Pathol 60:426-8. 2007..The cells in the papillary tumour contained three copies, whereas the oncocytoma cells contained only two per nucleus. To our knowledge, this is the first report of a papillary RCC being identified within an oncocytoma...
Clinical stage I seminoma: the case for surveillanceNathan Lawrentschuk
Division of Urology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
World J Urol 27:433-9. 2009..This review will focus on CSI seminoma and the controversies surrounding its treatment and based upon current available evidence will outline the case for surveillance...
A BRCA1 mutation is not associated with increased indicators of oxidative stressJoanne Kotsopoulos
Women s College Research Institute, Women s College Hospital, Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Ontario, Canada
Clin Breast Cancer 8:506-10. 2008..It is possible that individuals with a BRCA1 mutation might be susceptible to the effects of oxidative stress. The aim of this study was to evaluate whether women with a BRCA1 mutation exhibit increased indicators of oxidative stress...
Prevalence and predictors of selenium and vitamin E supplementation in a urology populationJennifer Locke
Urology Program, Princess Margaret Hospital University Health Network, Toronto, Ontario, Canada
J Altern Complement Med 19:128-33. 2013....
Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitorsNeil Fleshner
Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
J Urol 174:636-41; discussion 641; quiz 801. 2005..We determined if pharmacological dosages of phosphodiesterase type 5 inhibitors (PDE5) inhibitors were present within a group of natural products marketed for the treatment of erectile dysfunction...
Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-GuérinSultan S Alkhateeb
Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Canada
Urol Ann 3:119-26. 2011....
Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminologyTheodorus H van der Kwast
Department of Pathology and Laboratory Medicine, University Health Network and Mount Sinai Hospital, University of Toronto, Ontario, Canada
Anal Quant Cytol Histol 30:309-15. 2008..To harmonize nomenclature, we now propose that the terms low and high grade papillary urothelial carcinoma be replaced by low and high grade papillary intraurothelial neoplasiafor all noninvasive urothelial cancers...
The experiences of men receiving androgen deprivation treatment for prostate cancer: a qualitative studyRoss E Gray
Psychosocial and Behavioral Research Unit, Sunnybrook and Women's Health Sciences Centre, Toronto, Ontario, Canada
Can J Urol 12:2755-63. 2005..While men are grateful to receive potentially life-extending treatment, the challenge for the health care system is to provide them with the information and clinical support that will make their remaining years the best that they can be...
Prostate cancer prevention: past, present, and futureNeil Fleshner
Division of Urology, University Health Network, and Department of Surgery Urology, University of Toronto, Toronto, Ontario, Canada
Cancer 110:1889-99. 2007..Probably no cancer is being investigated more thoroughly in the context of prevention as prostate cancer in 2007. Definitive answers to pivotal phase 3 trials will be available in the coming 2 to 7 years...
MYH mutations are rare in prostate cancerEyun Jung Shin
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
J Cancer Res Clin Oncol 133:373-8. 2007..A compromised base-excision repair function due to defective MYH may contribute to prostate carcinogenesis. Here, we examine the genetic contribution of MYH to prostate cancer risk...
Development of prostate cancer quality indicators: a modified Delphi approachAnna R Gagliardi
Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada
Can J Urol 12:2808-15. 2005..These indicators can be used by individual providers and organizations to monitor the quality of their services, and develop interventions to address any variations...
Does the reflexive measurement of free PSA have a role in a tertiary cancer centre?Christopher Allard
University of Toronto, Toronto, ON
Can Urol Assoc J 4:317-20. 2010..We hypothesize that reflexive free PSA testing at tertiary cancer centres generates unnecessary costs as the test is often conducted on patients with previous diagnoses of prostate cancer...
Differences between urologists in United States and Canada in approach to bladder cancerDoreen Chung
Department of Surgery, Division of Urology, Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada
Urology 65:919-25. 2005....
Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progressionRichard Choo
Toronto-Sunnybrook Regional Cancer Center and Sunnybrook and Women's College Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
J Urol 167:1664-9. 2002....
Treatment of the inguinal regions in penile cancer: a review of the literature and treatment proposalDaniel Taussky
Department of Radiation Oncology and Surgical Oncology, Princess Margaret Hospital and the University Health Network, University of Toronto, Toronto, Ontario, Canada
Can J Urol 13:2978-83. 2006..The literature, which consists mainly of retrospective studies of patients treated over several decades, is not conclusive. We undertook a literature review to address this issue and to propose...
Controversies in the management of testicular seminomaNeil Fleshner
Division of Urology, Department of Surgery, Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada
Semin Urol Oncol 20:227-33. 2002..The high failure rate outside the treatment field has now changed this paradigm to one of up-front chemotherapy...
Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control studyJacek A Kopec
Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada
J Urol 174:495-9; discussion 499. 2005..There is limited evidence that screening is effective in reducing mortality from prostate cancer. In the current study we determined if screening with PSA reduces the risk of metastatic prostate cancer...
Radical prostatectomy as treatment for prostate cancerMichael A S Jewett
Uro-Oncology Program, Division of Urology, University of Toronto
CMAJ 168:44-5. 2003
An oncology perspective on the benefits and cost of combined androgen blockade in advanced prostate cancerArmen G Aprikian
Department of Surgery, McGill University, , , , Canada
Can J Urol 10:1986-94. 2003....
First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statementIan M Thompson
University of Texas Health Science Center at San Antonio, Texas 78229, USA
J Urol 171:S3-4. 2004
The role of bisphosphonates in the management of bone metastases in prostate cancerFred Saad
Department of Urology, University of Montreal (CHUM, Montreal, Quebec, Canada
Can J Urol 11:2376-82. 2004..This article reviews the burden of skeletal complications in patients with prostate cancer, and the evidence for the use of bisphosphonates for the treatment of skeletal morbidity in this patient population...
An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseasesChristopher P Evans
Department of Urology, University of California, Davis School of Medicine, 4860 Y St, Suite 3500, Sacramento, CA 95817, USA
BJU Int 95:743-9. 2005
Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literatureFred Saad
University of Montreal, CHUM, Hopital Notre Dame, Montreal, Quebec, Canada
Can J Urol 13:16-24. 2006..Is there a known association between duration of wait time beyond the recommended standard and clinical outcome (i.e. recurrence free survival, overall survival)?..
